- Implications of the first edition of the Korean expert consensus-based practice recommendations for transarterial chemoembolization in the management of hepatocellular carcinoma
-
Chung JW
- KMID: 2546405
- J Liver Cancer.
- 2023 Sep;23(2):235-237.
- doi: 10.17998/jlc.2023.06.29
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
-
Bae SH, Park HC
- KMID: 2546420
- J Liver Cancer.
- 2023 Sep;23(2):402-404.
- doi: 10.17998/jlc.2023.08.18
-
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic basidiobolomycosis masquerading as cholangiocarcinoma: a case report and literature review
-
Sehrawat R, Bansal N, Srivastava A, Malik D, Vij V
- KMID: 2546418
- J Liver Cancer.
- 2023 Sep;23(2):389-396.
- doi: 10.17998/jlc.2023.06.07
Basidiobolus ranarum is known to cause subcutaneous mycoses; however, rare cases of hepatic and gastrointestinal involvement by basidiobolomycosis have been reported. Hepatic basidiobolomycosis may be confused with a carcinoma on... -
- CITED
-
- Close
- SHARE
-
- Close
- Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
-
Lee SW, Kang MK, Zhang X
- KMID: 2546406
- J Liver Cancer.
- 2023 Sep;23(2):238-240.
- doi: 10.17998/jlc.2023.09.12
-
- CITED
-
- Close
- SHARE
-
- Close
- Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes
-
Yoon JH, Choi SK
- KMID: 2546411
- J Liver Cancer.
- 2023 Sep;23(2):300-315.
- doi: 10.17998/jlc.2023.08.27
Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management of early-stage HCC is often successful with highly efficacious treatment modalities such as liver transplantation, surgical resection, and radiofrequency... -
- CITED
-
- Close
- SHARE
-
- Close
- A single hepatic mass with two tales: hepatic tuberculosis and hepatocellular carcinoma
-
Koh YDI, Leow WQ
- KMID: 2546419
- J Liver Cancer.
- 2023 Sep;23(2):397-401.
- doi: 10.17998/jlc.2023.08.30
Hepatic tuberculosis (HTB) is an uncommon manifestation of tuberculous infections, and there has been no proven causal link between HTB and hepatocellular carcinoma (HCC). We herein present a rare case... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
-
Cho Y, Choi JW, Kwon H, Kim KY, Lee BC, Chu HH, Lee DH, Lee HA, Kim GM, Oh JS, Hyun D, Lee IJ, Rhim H, Research Committee of the Korean Liver Cancer Association
- KMID: 2546407
- J Liver Cancer.
- 2023 Sep;23(2):241-261.
- doi: 10.17998/jlc.2023.05.22
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging prognostication and tumor biology in hepatocellular carcinoma
-
Kadi D, Yamamoto MF, Lerner EC, Jiang H, Fowler KJ, Bashir MR
- KMID: 2546410
- J Liver Cancer.
- 2023 Sep;23(2):284-299.
- doi: 10.17998/jlc.2023.08.29
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, and represents a significant global health burden with rising incidence rates, despite a more thorough understanding of the etiology and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single nodule
-
Yu S, Jo HS, Yu YD, Choi Yj, Kim DS
- KMID: 2546417
- J Liver Cancer.
- 2023 Sep;23(2):377-388.
- doi: 10.17998/jlc.2023.08.24
Background/Aims: Although the Barcelona Clinic Liver Cancer staging system seems to underestimate the impact of curative-intent surgical resection for multifocal hepatocellular carcinoma (HCC), recent studies have indicated favorable results for... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
-
Jeong WK
- KMID: 2546409
- J Liver Cancer.
- 2023 Sep;23(2):272-283.
- doi: 10.17998/jlc.2023.08.25
Sonazoid contrast-enhanced ultrasonography (CEUS) is a promising technique for the detection and diagnosis of focal liver lesions, particularly hepatocellular carcinoma (HCC). Recently, a collaborative effort between the Korean Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
-
Kim TH, Kim BH, Cho YR, Koh YH, Park JW
- KMID: 2546413
- J Liver Cancer.
- 2023 Sep;23(2):330-340.
- doi: 10.17998/jlc.2023.04.14
Background/Aim: Radiotherapy (RT) is an effective local treatment for hepatocellular carcinoma (HCC). However, whether additional RT is safe and effective in patients with advanced HCC receiving atezolizumab plus bevacizumab remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
-
Mun K, Han J, Roh P, Park J, Kim G, Hur W, Jang J, Choi J, Yoon S, You Y, Choi H, Sung P
- KMID: 2546414
- J Liver Cancer.
- 2023 Sep;23(2):341-349.
- doi: 10.17998/jlc.2023.04.30
Background/Aim: Cancer-associated fibroblasts (CAFs) play an immunosuppressive role in the tumor microenvironment (TME) of human cancers; however, their characteristics and role in hepatocellular carcinoma (HCC) remain to be elucidated. Methods: Nine... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of treatment for hepatocellular carcinoma in elderly patients
-
Lee HA, Lee S, Lee HL, Song JE, Lee DH, Han S, Shim JH, Kim BH, Choi JY, Rhim H, Kim DY
- KMID: 2546416
- J Liver Cancer.
- 2023 Sep;23(2):362-376.
- doi: 10.17998/jlc.2023.08.03
Background/Aim: Despite the increasing proportion of elderly patients with hepatocellular carcinoma (HCC) over time, treatment efficacy in this population is not well established. Methods: Data collected from the Korean Primary Liver... -
- CITED
-
- Close
- SHARE
-
- Close
- A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
-
Lee YR
- KMID: 2546412
- J Liver Cancer.
- 2023 Sep;23(2):316-329.
- doi: 10.17998/jlc.2023.09.04
Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at an advanced stage. Advanced HCC has limited treatment options and often has a poor prognosis. For the... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
-
Lee MMP, Chan LL, Chan SL
- KMID: 2546408
- J Liver Cancer.
- 2023 Sep;23(2):262-271.
- doi: 10.17998/jlc.2023.07.17
Hepatocellular carcinoma (HCC) frequently presents as advanced stage with poor prognosis and high mortality. Systemic treatment is the treatment of choice for advanced disease. In 2007, the first multi-kinase inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
- Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
-
Kim N, Yu JI, Park HC, Hong JY, Lim HY, Goh MJ, Paik YH
- KMID: 2546415
- J Liver Cancer.
- 2023 Sep;23(2):350-361.
- doi: 10.17998/jlc.2023.08.10
Background/Aim: Patients with large (>5 cm) hepatocellular carcinoma (HCC) have limited treatment options, thus necessitating the identification of prognostic factors and the development of predictive tools. This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
